NPO Petrovax Pharm LLC
http://petrovax.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From NPO Petrovax Pharm LLC
Pacts In Medtech: BI, Inflammasome Work On Retinal Disease; Takeda And Prometheus Take On IBD
Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, research and development partnerships and commercial collaborations. This edition covers industry pacts that were signed in September and October 2019.
Priming Russia’s Pharma Industry For Innovation
The Russian government’s aggressive plan to modernize the country’s pharmaceutical industry is stimulating entrepreneurial activities, as well as a flurry of deal activity between local and foreign companies. Many uncertainties remain about the potential opportunities, however, as foreign companies try to sort out changing regulatory and business dynamics.
Abbott To Buy Russia's Petrovax In Deal Worth As Much As $500 Million
Abbott Laboratories plans to acquire Russia's Petrovax Pharm for as much as $500 million for access to the nation's 12th largest drug maker, a specialist in vaccines.
Emerging Markets Earnings Roundup: Roche, Johnson & Johnson, Abbott (Part 1)
Emerging markets were a mixed picture for Big Pharma in the third quarter, with China the clear leader, but overall key markets continued to see slower growth, which many blamed on the slowdown in the West.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice